|
|
2350 Mission College Boulevard Suite 1175
Santa Clara, CA 95054 USA
phone:408.516.5000
fax:408.907.8923
|
|
| Symbol |
NWCI |
| Exchange |
OTC BB |
| Founded |
2004 |
| Employees |
10 |
|
|
| www.newcardio.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Products improving the accuracy of the standard ECG. |
|
| Management |
| Branislav Vajdic, PhD, CEO / Co-Founder, Board Member; Vincent J. Renz, President; Richard Brounstein, Chief Financial Officer; Ihor Gussak, MD, PhD, FACC, Chief Medical Officer and Vice President; Ihor Gussak, MD, PhD, FACC, Chief Medical Officer and Vice President; Dr. Dorin Panescu, Chief Technology Officer |
| |
|
|
|
|
|
|
|
| Keywords |
| cardiology, ECG, algorithm, cardiac, diagnostic, electrical activity, New Cardio |
|
|
|
| Description |
|
NewCardio, a cardiac diagnostic and services company, develops proprietary 3D platform technology to improve accuracy and significantly increase the diagnostic value of the standard 12-lead electrocardiogram (ECG). NewCardio�s products incorporate novel, state-of-the-art technology to significantly improve the diagnostic precision of the analysis and use of signals from ECGs, without disrupting the well-established 12-lead ECG practice. The Company�s technology is based on a 3D approach to modeling cardiac activity using standard 12-lead ECG signals. |
|
| Products / Services |
NewCardio's product portfolio consists of QTinno?, Visual3Dx? and CardioBip?. QTinno? is a software suite that provides fully automated analysis of QT intervals and other ECG-based cardiac safety for the pharmaceutical industry. CardioBip? addresses the problem of urgent ECG telemonitoring and is capable of providing far more comprehensive and accurate transtelephonic ECG data than other integrated devices used today. Visual3Dx? is a diagnostic tool for 3D quantitative analysis of cardiac electrical activity in time and space. It transforms the ECG input into a time-variable heart vector, normalizing each lead input to assure equal representation from all cardiac regions of the heart.
|
|
| Technology / Differentiation |
| QTinno? provides fast, accurate and precise QT data from a broad range of challenging ECGs, analyzing greater than 10,000 ECGs within an hour. It synthesizes information from all 12 leads into a 3D representation of cardiac electrical activity over time, generates a ?virtual? ECG lead, and utilizes all available beats. It incorporates novel, curve fitting algorithms and a "confidence factor" that flags the most difficult ECGs for recommended cardiologist over read. The Cardiobip? solution consists of a mobile ECG recording, a transmitting device, and a diagnostic center which receives, processes, and analyzes the data. The data collected provides sufficient information to allow immediate reconstruction of a complete 12-lead ECG from a calibrated, patient-specific transformation matrix. This enables more accurate, timely diagnoses of acute cardiac events, and facilitates immediate intervention in life-threatening situations. Visual3Dx?, with improved sensitivity and specificity, adds significant diagnostic value in the initial evaluation of patients in urgent care settings. It is a promising tool for patients entering the Emergency Room with chest pain and has the potential to improve the diagnosis of acute myocardial ischemia. |
|
| Market / Customers |
NewCardio continues to penetrate the marketplace, gaining traction with its Corelab, CRO, and PhI partners. With such an advanced 3D platform, they have the opportunity to be a disruptive force in markets that exceed $4.5 billion in aggregate annually.
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members